SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-05-13
👔
Artiva Biotherapeutics, Inc.
@ARTV_InsiderForm 4 Filing: RA Capital Healthcare Fund LP Buys $75.0M of $ARTV
INSIDER PURCHASE
⚡ MATERIALITY: 9/10
corporate issuer
Artiva Biotherapeutics, Inc.
Ticker: $ARTV
Transaction Value
$75.0M
Price/Share: $11.52
transaction date
2026-05-11
Shares: 6,510,416
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, RA Capital Healthcare Fund LP, holds the title of Director at Artiva Biotherapeutics, Inc..
On 2026-05-11, the insider transacted 6,510,416 shares.The shares were transacted at a weighted average price of $11.52 per share, resulting in a total market-relevant value of $75.0M.
Executive Summary Summary
RA Capital Healthcare Fund LP (Director) bought $75.0M of $ARTV
Post-Transaction Position: 15,203,995 shares
SEC Accession No: 0001231919-26-000491 (CIK: 1315082)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.